Investments and Business

Blink Fitness, Equinox’s Affordable Gym Chain, Files for Bankruptcy Protection

Blink Fitness, Equinox’s Affordable Gym Chain, Files for Bankruptcy Protection

Budget gym chain Blink Fitness, a subsidiary of luxury fitness conglomerate Equinox Group, has filed for Chapter 11 bankruptcy protection. The move comes as the fitness industry continues to grapple with the economic fallout from the pandemic. With more than 100 locations nationwide, Blink Fitness joins a growing list of gym chains seeking bankruptcy protection, including industry mainstays like New York Sports Club, 24 Hour Fitness and Gold’s Gym. The company aims to streamline operations and facilitate a sale through the bankruptcy process while maintaining normal gym operations. Blink Fitness’s parent company, Equinox Group, has been on a financial rollercoaster.…
Read More
DirecTV Goes Beyond the Satellite Dish

DirecTV Goes Beyond the Satellite Dish

DirecTV is undergoing a radical transformation, shifting its focus from traditional satellite television to streaming services. The company is aggressively promoting its dish-free options, aiming to attract a new generation of cord-cutters and retain existing customers. A recent ad campaign featuring Deion Sanders, Steve Buscemi, and Henry Winkler has been instrumental in raising awareness of DirecTV’s streaming capabilities. The humorous commercials playfully address the misconception that a satellite dish is still required for service, emphasizing the convenience and flexibility of the company’s streaming platform. While satellite TV remains a core part of DirecTV’s business, the company is recognizing the changing…
Read More
Eli Lilly’s Profits Skyrocket on Success of Mounjaro and Zepbound

Eli Lilly’s Profits Skyrocket on Success of Mounjaro and Zepbound

Pharmaceutical giant Eli Lilly delivered a stellar second-quarter performance, beating analysts’ expectations and raising its full-year outlook by a whopping $3 billion. The company’s flagship diabetes drug, Mounjaro, and its weight-loss counterpart, Zepbound, were the main drivers of the stellar growth. Mounjaro and Zepbound, both incretin drugs, have seen unprecedented demand, leading to supply constraints that Eli Lilly is aggressively addressing. The company has invested heavily in expanding manufacturing capacity, resulting in a 50% increase in production of these drugs in the second half of 2024 versus the prior year. Despite supply challenges, Eli Lilly’s revenues increased 36% year-over-year to…
Read More
Elf Beauty Revenue Increases 50% on New Product Launches and Strong Performance in Cosmetics and Skincare

Elf Beauty Revenue Increases 50% on New Product Launches and Strong Performance in Cosmetics and Skincare

Elf Beauty continues its upward trajectory in the cosmetics sector, recording a significant 50% increase in sales this quarter. In its first fiscal quarter, Elf Beauty’s revenue hit $324.5 million, allowing the company to increase its full-year projections. This growth is a continuation of a 76% increase reported in the same quarter last year. In an interview with CNBC, CEO Tarang Amin noted that growth has been consistent across all product categories. The newly launched Bronzing Drops serum emerged as a bestseller on Elf’s website shortly after its launch. An analysis of the company's financial performance versus Wall Street forecasts,…
Read More